Literature DB >> 10225943

Gamma interferon and interleukin-10 gene expression in synovial tissues from patients with early stages of Chlamydia-associated arthritis and undifferentiated oligoarthritis and from healthy volunteers.

S Kotake1, H R Schumacher, T K Arayssi, H C Gérard, P J Branigan, A P Hudson, C H Yarboro, J H Klippel, R L Wilder.   

Abstract

Genetically determined differences in interleukin-10 (IL-10) and gamma interferon (IFN-gamma) responses in mice correlate with clearance of Chlamydia pneumonitis infection. We measured the synovial expression of IL-10 and IFN-gamma and additional cytokine genes in patients who had recent-onset Chlamydia-associated arthritis (Chl-AA). IL-10 and IFN-gamma mRNA were relatively abundant in recent-onset Chl-AA.

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10225943      PMCID： PMC116026     

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  22 in total

1.  Genes required for assembly and function of the protein synthetic system in Chlamydia trachomatis are expressed early in elementary to reticulate body transformation.

Authors:  H C Gérard; J A Whittum-Hudson; A P Hudson
Journal:  Mol Gen Genet       Date:  1997-08

2.  A simple nested RT-PCR method for quantitation of the relative amounts of multiple cytokine mRNAs in small tissue samples.

Authors:  S Kotake; H R Schumacher; R L Wilder
Journal:  J Immunol Methods       Date:  1996-12-15       Impact factor: 2.303

3.  In vivo gene expression of type 1 and type 2 cytokines in synovial tissues from patients in early stages of rheumatoid, reactive, and undifferentiated arthritis.

Authors:  S Kotake; H R Schumacher; C H Yarboro; T K Arayssi; J A Pando; K S Kanik; M F Gourley; J H Klippel; R L Wilder
Journal:  Proc Assoc Am Physicians       Date:  1997-05

4.  Immunity to Chlamydia trachomatis is mediated by T helper 1 cells through IFN-gamma-dependent and -independent pathways.

Authors:  L L Perry; K Feilzer; H D Caldwell
Journal:  J Immunol       Date:  1997-04-01       Impact factor: 5.422

5.  Genetically determined differences in IL-10 and IFN-gamma responses correlate with clearance of Chlamydia trachomatis mouse pneumonitis infection.

Authors:  X Yang; K T HayGlass; R C Brunham
Journal:  J Immunol       Date:  1996-06-01       Impact factor: 5.422

6.  Crucial role of interleukin-10/interleukin-12 balance in the regulation of the type 2 T helper cytokine response in reactive arthritis.

Authors:  Z Yin; J Braun; L Neure; P Wu; L Liu; U Eggens; J Sieper
Journal:  Arthritis Rheum       Date:  1997-10

7.  Comparison of synovial tissue and synovial fluid as the source of nucleic acids for detection of Chlamydia trachomatis by polymerase chain reaction.

Authors:  P J Branigan; H C Gérard; A P Hudson; H R Schumacher; J Pando
Journal:  Arthritis Rheum       Date:  1996-10

8.  Alteration of Chlamydia trachomatis biologic behavior in synovial membranes. Suppression of surface antigen production in reactive arthritis and Reiter's syndrome.

Authors:  R Nanagara; F Li; A Beutler; A Hudson; H R Schumacher
Journal:  Arthritis Rheum       Date:  1995-10

Review 9.  Pathogenesis of spondylarthropathies. Persistent bacterial antigen, autoimmunity, or both?

Authors:  J Sieper; J Braun
Journal:  Arthritis Rheum       Date:  1995-11

10.  Inhibition of apoptosis in chlamydia-infected cells: blockade of mitochondrial cytochrome c release and caspase activation.

Authors:  T Fan; H Lu; H Hu; L Shi; G A McClarty; D M Nance; A H Greenberg; G Zhong
Journal:  J Exp Med       Date:  1998-02-16       Impact factor: 14.307
View more
  14 in total

Review 1.  Pathogenesis of reactive arthritis.

Authors:  J Sieper
Journal:  Curr Rheumatol Rep       Date:  2001-10       Impact factor: 4.592

Review 2.  Immunological basis of Chlamydia induced reactive arthritis.

Authors:  J S Gaston
Journal:  Sex Transm Infect       Date:  2000-06       Impact factor: 3.519

Review 3.  Reactive arthritis or chronic infectious arthritis?

Authors:  J Sibilia; F-X Limbach
Journal:  Ann Rheum Dis       Date:  2002-07       Impact factor: 19.103

Review 4.  Significant roles played by IL-10 in Chlamydia infections.

Authors:  Hamid Hakimi; Mohammad Zare-Bidaki; Nahid Zainodini; Shokrollah Assar; Mohammad Kazemi Arababadi
Journal:  Inflammation       Date:  2014-06       Impact factor: 4.092

5.  HLA-B27-transfected (Salmonella permissive) and HLA-A2-transfected (Salmonella nonpermissive) human monocytic U937 cells differ in their production of cytokines.

Authors:  Päivi Ekman; Marja Saarinen; Qiushui He; Christel Gripenberg-Lerche; Alvar Grönberg; Heikki Arvilommi; Kaisa Granfors
Journal:  Infect Immun       Date:  2002-03       Impact factor: 3.441

6.  The molecular basis for disease phenotype in chronic Chlamydia-induced arthritis.

Authors:  John D Carter; Herve C Gerard; Judith A Whittum-Hudson; Alan P Hudson
Journal:  Int J Clin Rheumtol       Date:  2012-12-01

7.  An elevated level of IL-10- and TGFbeta-secreting T cells, B cells and macrophages in the synovial membrane of patients with reactive arthritis compared to rheumatoid arthritis.

Authors:  Heiner Appel; Lucia Neure; Maren Kuhne; Jürgen Braun; Martin Rudwaleit; Joachim Sieper
Journal:  Clin Rheumatol       Date:  2004-07-28       Impact factor: 2.980

Review 8.  Disease mechanisms in reactive arthritis.

Authors:  Joachim Sieper
Journal:  Curr Rheumatol Rep       Date:  2004-04       Impact factor: 4.592

9.  Chlamydia trachomatis heat shock protein-60 induced interferon-gamma and interleukin-10 production in infertile women.

Authors:  A Kinnunen; H-M Surcel; M Halttunen; A Tiitinen; R P Morrison; S G Morrison; P Koskela; M Lehtinen; J Paavonen
Journal:  Clin Exp Immunol       Date:  2003-02       Impact factor: 4.330

10.  Host immune responses to chlamydial inclusion membrane proteins B and C in Chlamydia trachomatis infected women with or without fertility disorders.

Authors:  Rishein Gupta; Pragya Srivastava; Harsh Vardhan; Sudha Salhan; Aruna Mittal
Journal:  Reprod Biol Endocrinol       Date:  2009-04-28       Impact factor: 5.211
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.